Mraz M, Haluzik M (2014) The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 222(3):R113–R127. https://doi.org/10.1530/JOE-14-0283

Article  CAS  PubMed  Google Scholar 

Foster CS (2000) Pathology of benign prostatic hyperplasia. Prostate Suppl 9:4–14. https://doi.org/10.1002/1097-0045(2000)45:9+%3c4::aid-pros3%3e3.0.co;2-q

Article  CAS  PubMed  Google Scholar 

García-Flórez M, Oliveira CA, Carvalho HF (2005) Early effects of estrogen on the rat ventral prostate. Braz J Med Biol Res 38(4):487–497. https://doi.org/10.1590/s0100-879x2005000400002

Article  PubMed  Google Scholar 

Chughtai B, Forde JC, Thomas DD et al (2016) Benign prostatic hyperplasia. Nat Rev Dis Primers 2:16031. https://doi.org/10.1038/nrdp.2016.31

Article  PubMed  Google Scholar 

Langan RC (2019) Benign prostatic hyperplasia. Prim Care 46(2):223–232. https://doi.org/10.1016/j.pop.2019.02.003

Article  PubMed  Google Scholar 

Cicero AFG, Allkanjari O, Busetto GM et al (2019) Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch Ital Urol Androl. https://doi.org/10.4081/aiua.2019.3.139

Article  PubMed  Google Scholar 

van Breemen RB, Pajkovic N (2008) Multitargeted therapy of cancer by lycopene. Cancer Lett 269(2):339–351. https://doi.org/10.1016/j.canlet.2008.05.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Basu A, Imrhan V (2007) Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J Clin Nutr 61(3):295–303. https://doi.org/10.1038/sj.ejcn.1602510

Article  CAS  PubMed  Google Scholar 

Chen J, Song Y, Zhang L (2013) Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J Nutr Sci Vitaminol (Tokyo) 59(3):213–223. https://doi.org/10.3177/jnsv.59.213

Article  CAS  PubMed  Google Scholar 

Clinton SK (2005) Tomatoes or lycopene: a role in prostate carcinogenesis? J Nutr 135(8):2057S-2059S. https://doi.org/10.1093/jn/135.8.2057S

Article  CAS  PubMed  Google Scholar 

Limpens J, Schröder FH, de Ridder CMA et al (2006) Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr 136(5):1287–1293. https://doi.org/10.1093/jn/136.5.1287

Article  CAS  PubMed  Google Scholar 

Chen L, Stacewicz-Sapuntzakis M, Duncan C et al (2001) Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. JNCI J Natl Cancer Inst 93(24):1872–1879. https://doi.org/10.1093/jnci/93.24.1872

Article  CAS  PubMed  Google Scholar 

Mohanty NK, Saxena S, Singh UP et al (2005) Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol 23(6):383–385. https://doi.org/10.1016/j.urolonc.2005.05.012

Article  CAS  PubMed  Google Scholar 

Arts IC, Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81(1 Suppl):317S-325S. https://doi.org/10.1093/ajcn/81.1.317S

Article  CAS  PubMed  Google Scholar 

Huxley RR, Neil HAW (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 57(8):904–908. https://doi.org/10.1038/sj.ejcn.1601624

Article  CAS  PubMed  Google Scholar 

Yang XB, Zhao Y, Yang Y, Ruan Y (2008) Isolation and characterization of immunostimulatory polysaccharide from and herb tea, Gynostemma pentaphyllum Makino. J Agric Food Chem 56:6905–6909. https://doi.org/10.1021/jf801101u

Article  CAS  PubMed  Google Scholar 

Paubert-Braquet M, Cousse H, Raynaud JP et al (1998) Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies. Eur Urol 33(3):340–347. https://doi.org/10.1159/000019570

Article  CAS  PubMed  Google Scholar 

Silvestri I, Cattarino S, Aglianò A et al (2013) Effect of Serenoa repens ( Permixon ®) on the expression of inflammation-related genes : analysis in primary cell cultures of human prostate carcinoma. J Inflamm 10:11. https://doi.org/10.1186/1476-9255-10-11

Article  Google Scholar 

Perry R, Milligan G, Anderson P et al (2012) Real-world use of Permixon® in benign prostatic hyperplasia–determining appropriate monotherapy and combination treatment. Adv Ther 29(6):538–550. https://doi.org/10.1007/s12325-012-0024-x

Article  CAS  PubMed  Google Scholar 

Allkanjari O, Vitalone A (2015) What do we know about phytotherapy of benign prostatic hyperplasia? Life Sci 126:42–56. https://doi.org/10.1016/j.lfs.2015.01.023

Article  CAS  PubMed  Google Scholar 

Levin RM, Das AK (2000) A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 28(3):201–209. https://doi.org/10.1007/s002409900098

Article  CAS  PubMed  Google Scholar 

Governa P, Giachetti D, Biagi M et al (2016) Hypothesis on Serenoa Repens (Bartram) small extract inhibition of prostatic 5α-reductase x-ray structure. Peer J 4:e2698. https://doi.org/10.7717/peerj.2698

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colado-Velázquez JI, Mailloux-Salinas P, Medina-Contreras J et al (2015) Effect of Serenoa Repens on oxidative stress, inflammatory and growth factors in obese Wistar rats with benign prostatic hyperplasia. Phytother Res 10:1525–1531. https://doi.org/10.1002/ptr.5406

Article  Google Scholar 

Minutoli L, Bitto A, Squadrito F et al (2013) Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia. Curr Med Chem 20(10):1306–1312. https://doi.org/10.2174/0929867311320100007

Article  CAS  PubMed  Google Scholar 

Di Silverio F, Bosman C, Salvatori M et al (2005) Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Eur Urol 47(1):72–78. https://doi.org/10.1016/j.eururo.2004.08.024

Article  CAS  PubMed  Google Scholar 

Carraro JC, Raynaud JP, Koch G et al (1996) Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 29(4):231–240. https://doi.org/10.1002/(SICI)1097-0045(199610)29:4%3c231

Article  PubMed  Google Scholar 

Geavlete P, Multescu R, Geavlete B (2011) Serenoa repens extract in the treatment of benign prostatic hyperplasia. Ther Adv Urol 3(4):193–198. https://doi.org/10.1177/1756287211418725

Article  PubMed  PubMed Central  Google Scholar 

Espinosa-Juárez J, Colado-Velázquez JIII, Mailoux-Salinas P et al (2017) Beneficial effects of lipidic extracts of saladette tomato pomace and Serenoa repens on prostate and bladder health in obese male Wistar rats. J Sci Food Agric 97(13):4451–4458. https://doi.org/10.1002/jsfa.8308

Article  CAS  PubMed  Google Scholar 

Altavilla D, Bitto A, Polito F et al (2011) The combination of Serenoa Repens, Selenium and Lycopene is more effective than Serenoa repens alone to prevent hormone dependent prostatic growth. J Urol 186:1524–1529. https://doi.org/10.1016/j.juro.2011.05.049

Article  CAS  PubMed  Google Scholar 

Colado-Velazquez JIII et al. (2021) Extracto de Tomate (Lycopersicum esculentum) para el tratamiento de hiperplasia de próstata en obesidad. (Mexico, Mexico Patent No. 380295). Mexicano de la Protección Industrial. https://www.gob.mx

Fish WW, Perkins-Veazie P, Collins JK (2002) A quantitative assay for lycopene that utilizes reduced volumes of organic solvents. J Food Compos Anal 15(3):309–317. https://doi.org/10.1006/jfca.2002.1069

Article  CAS  Google Scholar 

Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5(1):62–71. https://doi.org/10.1006/niox.2000.0319

Article  CAS  PubMed  Google Scholar 

Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358. https://doi.org/10.1016/0003-2697(79)90738-3

Article  CAS  PubMed  Google Scholar 

Lee S, Min HG, Choi SH et al (2006) Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 14(1):172–179. https://doi.org/10.1038/oby.2006.21

Article  PubMed  Google Scholar 

Kristal AR, Arnold KB, Schenk JM et al (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177(4):1395–1400. https://doi.org/10.1016/j.juro.2006.11.065

Article  PubMed  Google Scholar 

Lokeshwar SD, Harper BT, Webb E et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8(5):529–539. https://doi.org/10.21037/tau.2019.10.01

Article  PubMed  PubMed Central  Google Scholar 

Patel ND, Parsons JK (2014) Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol 30(2):170–176. https://doi.org/10.4103/0970-1591.126900

Article  PubMed  PubMed Central